progressive supranuclear palsy program (Verge Genomics)

N/A

Report date: 2025/03/20 09:50:01
NME

Base Information

Drug Nameprogressive supranuclear palsy program (Verge Genomics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerge Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVerge Genomics Inc
Inactive CompaniesN/A
Active IndicationsSupranuclear Palsy, Progressive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A